Unquoted Search Path Vulnerability in Philips IntelliSpace Cardiovascular Products
CVE-2018-14789

6.7MEDIUM

Key Information:

Vendor

Philips
Status
Intellispace Cardiovascular (iscv) Products
Vendor
CVE Published:
22 August 2018

What is CVE-2018-14789?

An unquoted search path vulnerability has been discovered in Philips' IntelliSpace Cardiovascular (ISCV) and Xcelera products. This flaw allows an attacker to potentially execute arbitrary code on the affected systems, thereby escalating their privileges. Specifically, versions of the ISCV released prior to 3.1 and Xcelera versions prior to 4.1 are at risk. It is crucial for users to assess their systems and apply necessary protections to mitigate this security issue.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

IntelliSpace Cardiovascular (ISCV) products IntelliSpace Cardiovascular, Version 3.1 or prior

IntelliSpace Cardiovascular (ISCV) products Xcelera Version 4.1 or prior

References

https://www.usa.philips.com/healthcare/about/customer-sup...
x_refsource_CONFIRM
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
x_refsource_MISC

CVSS V3.1

Score:
6.7
Severity:
MEDIUM
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
High
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.